June 28, 2021

International experts join Microba Life Sciences inaugural IBD Advisory Panel

BRISBANE, AustraliaJune 28, 2021 /PRNewswire/ — Precision microbiome science company, Microba Life Sciences, has appointed three respected key opinion leaders in Inflammatory Bowel Disease (IBD) to their IBD Advisory Panel to translate research into clinical outcomes for IBD sufferers.

Professors from Mount Sinai Doctors, Professor Jean-Frederic Colombel, MD and University of Miami Health System, Professor Maria Teresa Abreu will join with Australia’s Associate Professor Jake Begun from Mater Health to guide the company’s therapeutic programs to address major unmet clinical needs associated with IBD treatment.

Read More…